期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

吉西他滨联合奥沙利铂治疗晚期胰腺癌32例临床观察 被引量：7

下载PDF
导出
摘要 胰腺癌是一种恶性度非常高的消化系统肿瘤，近年来发病率呈现明显的增加趋势。其病死率在恶性肿瘤中占第5位。因早期无明显症状和体征，胰腺癌早期发现困难，临床多见中晚期，手术根治疗效差，病程短，5年生存率仅5％。
作者 张素珍 刘俊 杨牡丹 高峻 刘晓玲
机构地区 山西省肿瘤医院消化科 山西省人民医院消化科
出处 《中国药物与临床》 CAS 2013年第8期1091-1092,共2页 Chinese Remedies & Clinics
关键词 晚期胰腺癌 临床观察 奥沙利铂 吉西他滨 治疗 消化系统肿瘤 5年生存率 恶性肿瘤
分类号 R735.9 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1周际昌.实用肿瘤内科学.2版.北京:人民卫生出版社,2000:619-625.
  • 2Min YJ, Joo KR, Park NH,et al. Gemcitabine therapy in pa-tients with advanced pancreatic cancer. Korean J Intern Med,2002, 17(4):259-262.
  • 3Tsuchida Y, Therasse P. Response evaluation criteria in solidtumors (RECIST) ; new guidelines. Med Pediatr Oncol, 2001,37(1):1-3.
  • 4吴娜,梁晓丽.健择[J].中国新药杂志,2000,9(3):204-205. 被引量：45
  • 5Prost P, Ychou M, Azria D. Gemcitabine and pancreatic cancer.Bull Cancer,2002,89:S91-S95.
  • 6Heinemann V, Quietzsch D, Gieseler F,et al. Randomizedphase M trial of gemcitabine plus cisplatin compared with gemc-itabine alone in advanced pancreatic cancer. J Clin Oncol,2006,24(24):3946-3952.
  • 7王晓稼.抗肿瘤新药吉西他滨临床研究进展[J].肿瘤学杂志,2005,11(1):69-71. 被引量：26
  • 8邰雅宏,王亚东.吉西他滨静脉滴注治疗晚期胰腺癌疗效分析[J].湘南学院学报（自然科学版）,2004,6(4):7-8. 被引量：3
  • 9Kim HR, Min BS, Kim JS, et al. Efficacy of oxaliplatin-basedchemotherapy in curatively resected colorectal cancer with livermetastasis. 0ncology,2011,81(3/4) ; 175-183.

二级参考文献38

  • 1[1]Laack E, Mende T, Durk H, et al . Gemcitabine, vinorelbine and cisplatin combination chemotheraphy in advanced nonsmall cell lung cancer. a phase Ⅱ trial[J]. Eur Cancer, 2002,38: 654 - 560.
  • 2[2]Salman HS, Tanaka K, Sparano JA. Phase Ⅰ/Ⅱ trial of gemcitabine plus cyclophsphamide in patients with metastatic breast carcinoma previously treated with taxanes[J].Clin Breast Cancer, 2002 , 299 - 303.
  • 3[3]D'Agostino G, Ferrandina G, Garganese G, et al. Phase Ⅰ study of gemcitabine and liposomal Doxorubicin in relapsed ovarian cancer[J]. Oncology, 2002, 62: 110- 114.
  • 4[5]Alter Cl. Palliative and supportive care of patients with pancreative cancer[J]. Semin Oncol , 1996 , 23: 229- 240.
  • 5[6]Havard JM. Jordan GL Jr . Cancer of the pancreas [ J ]. Curr Prob Cancer, 1997, 2: 1-52.
  • 6[7]Cartwright TH , Cohn A , Varkey JA , et al. Phase Ⅱ study of oral capecitabine in patients with advanced or metastatic pancreatic cancer[J]. J Clin Oncol ,2002 , 20: 160- 164.
  • 7[8]Huguier M, Barrier A, Valinas R, etal. Phase Ⅰ trial of 5- luorouracil, leucovorin and cisplatin in advanced pancreatic cancer[J]. Hepatogastroenterology, 2001, 48: 875-878.
  • 8[9]Wolff RA, Evance DB, Gravel D, et al. Phase Ⅰ trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma[J]. Clin Cancer Res, 2001,7: 2246- 2253.
  • 9[10]Ehta VK, Poen JC, Ford JM, et al. Protracted venous infusion 5- fluorouracil for unresectable pancreatic cancer[J]. Am J Clin Oncol , 2001, 24: 155- 159.
  • 10IALT(The International Adjuvant Lung Cancer Trial Collaborative Group). Cisplatin-based adjuvant chemotherapy in patients with completely resected Non-small-cell lung cancer[J]. N Engl J Med, 2004,350:351-360.

共引文献69

同被引文献51

  • 1程月鹃,白春梅,张在军.吉西他滨联合厄洛替尼治疗进展期胰腺癌的疗效观察[J].中国医学科学院学报,2010,32(4):421-423. 被引量：10
  • 2陈东升,吴光兴,唐丽珠.胰腺癌根治术后行吉西他滨联合替吉奥化疗的临床观察[J].实用癌症杂志,2014,29(1):78-80. 被引量：19
  • 3郑家平,叶强,顾伟中.胰腺癌的血管介入治疗[J].介入放射学杂志,2004,13(4):373-375. 被引量：14
  • 4黄强 翟仁友.中晚期胰腺癌的介入治疗.中国介入放射学,2008,2(1):77-82.
  • 5Hart GH,Yin ZX,Meng X J, et al.Prospect ive randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma[J]. Chin J Dig Dis,2006;7( 1): 45-48.
  • 6史艳侠,徐瑞华,姜文奇,张力,林桐榆,李宇红,夏忠军,骆卉研,韩冰,王峰,何友兼,管忠震.吉西他滨联合奥沙利铂治疗晚期胰腺癌患者的疗效[J].癌症,2007,26(12):1381-1384. 被引量：11
  • 7.抗癌药急性及亚急性毒性反应分度标准(WHO标准)[J].癌症.1992(03)
  • 8Takuji Okusaka,Akihiro Funakoshi,Junji Furuse,Narikazu Boku,Kenji Yamao,Shinichi Ohkawa,Hiroshi Saito.A late phase II study of S-1 for metastatic pancreatic cancer[J].Cancer Chemotherapy and Pharmacology.2008(4)
  • 9Hidekazu Kuramochi,Kazuhiko Hayashi,Kazumi Uchida,Go Nakajima,Takashi Hatori,Kathleen D. Danenberg,Peter V. Danenberg,Masakazu Yamamoto.High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1[J].Cancer Chemotherapy and Pharmacology.2008(1)
  • 10Laheru D,Biedrzyek B,homas AM,et al.Development of a cytokine modified allogeneie hole cell pancreatic cancer vaccine[J].Methods Mol Med,2005,103(10):299-327.

引证文献7

二级引证文献51

中国药物与临床
2013年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部